Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) earns a place on our top 10 stocks under $5 that could triple. Analysts Remain Confident in Reviva Pharmaceuticals Holdings (RVPH) Amid 1-for-20 Reverse Stock Split As of March 19, 2026, 83% of covering analysts maintain bullish ratings for Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) with a consensus price target of $40.00, indicating 2,073.91% upside despite share price pressure. Nevertheless, D. Boral Capital took a more cautious approach by ...